Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Colorectal Neoplasms 1Barrett Esophagus 1Adenomatous Polyposis Coli 1Adenocarcinoma of the Esophagogastric Junction 1Adenocarcinoma Of Esophagus 1

Interventions

Sulindac 2Specimen Handling 2Sirolimus 2Erlotinib Hydrochloride 2Endoscopy, Gastrointestinal 2Curcumin 2Celecoxib 2Biopsy 2obeticholic acid 1Surveys and Questionnaires 1Probiotics 1Pharmaceutical Preparations 1Niclosamide 1Metformin 1Lithium Carbonate 1Inulin 1Gastroscopy 1Endoscopy, Digestive System 1Eflornithine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Adenomatous Polyposis Coli × Endoscopy, Digestive System × Clear all
NCT06557733 2026-05-13

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

National Cancer Institute (NCI)

Phase 2 Recruiting
38 enrolled
Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡